AbbVie Inc. operates as a global pharmaceutical enterprise, concentrating on the discovery, development, production, and commercialization of medicinal products across the world. Its extensive product portfolio addresses various therapeutic areas. For autoimmune and inflammatory conditions, the company provides HUMIRA, an injectable treatment for autoimmune and intestinal Behçet's diseases; SKYRIZI, aimed at adults with moderate to severe plaque psoriasis; and RINVOQ, a JAK inhibitor prescribed for moderate to severe active rheumatoid arthritis in adult patients.